SAGE THERAPEUTICS, INC.

(SAGE)
  Report
Real-time Estimate Cboe BZX  -  10:56 2022-08-10 am EDT
42.84 USD   +1.66%
08/03Goldman Sachs Adjusts Sage Therapeutics' Price Target to $73 From $74, Keeps Buy Rating
MT
08/03Citigroup Trims Price Target on Sage Therapeutics to $40 From $41, Maintains Neutral Rating
MT
08/03Wedbush Trims Price Target on Sage Therapeutics to $52 From $54, Keeps Outperform Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on SAGE THERAPEUTICS, INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) SAGE THERAPEUTICS, INC.
Analyst Recommendations on SAGE THERAPEUTICS, INC.
08/03Goldman Sachs Adjusts Sage Therapeutics' Price Target to $73 From $74, Keeps Buy Rating
MT
08/03Citigroup Trims Price Target on Sage Therapeutics to $40 From $41, Maintains Neutral Ratin..
MT
08/03Wedbush Trims Price Target on Sage Therapeutics to $52 From $54, Keeps Outperform Rating
MT
07/11SVB Securities Adjusts Sage Therapeutics' Price Target to $40 from $50, Keeps Market Perfo..
MT
07/01Berenberg Bank Terminates Coverage of 85 Companies in Consumer Discretionary, Healthcare, ..
MT
06/02RBC Capital Adjusts Price Target for Sage Therapeutics to $37 From $35, Maintains Sector P..
MT
05/24Goldman Sachs Lowers Sage Therapeutics' Price Target to $73 From $85, Maintains Buy Rating
MT
More recommendations
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 42,14 $
Average target price 57,81 $
Spread / Average Target 37,2%
High Price Target 105,00 $
Spread / Highest target 149%
Low Price Target 32,00 $
Spread / Lowest Target -24,1%
Consensus detail
Consensus revision (last 18 months)